Axi Showcases Their Capital Allocation Program, Axi Select, at the Finance Magnates Africa Summit 6-06-2025, 16:00

Scientists report studies showing a novel drug repairs myelin and restores nervous system function in a model of multiple sclerosis 24-12-2024, 00:58

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00